Regional Pathways, Global Evidence: Advancing NGS-Based CDx Development

• Global NGS product portfolio supporting biomarker testing across multiregional clinical trials
• Explore regional CDx development approaches informed by experience across China, Japan, and Europe
• Integrated capabilities supporting consistent evidence generation across regions and global CDx development

Speakers:

Michael Chen

Senior Translational Medicine Scientist

Burning Rock Dx